ATE4166T1 - Langwirkende injizierbare sulfonamidzusammensetzungen. - Google Patents

Langwirkende injizierbare sulfonamidzusammensetzungen.

Info

Publication number
ATE4166T1
ATE4166T1 AT80302190T AT80302190T ATE4166T1 AT E4166 T1 ATE4166 T1 AT E4166T1 AT 80302190 T AT80302190 T AT 80302190T AT 80302190 T AT80302190 T AT 80302190T AT E4166 T1 ATE4166 T1 AT E4166T1
Authority
AT
Austria
Prior art keywords
long
sulfonamide
acting injectable
compositions
solution
Prior art date
Application number
AT80302190T
Other languages
English (en)
Inventor
William Wellesley Armstrong
Saurabhkumar Jayavantrai Sheela Desai
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Application granted granted Critical
Publication of ATE4166T1 publication Critical patent/ATE4166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
AT80302190T 1979-07-02 1980-06-30 Langwirkende injizierbare sulfonamidzusammensetzungen. ATE4166T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5431379A 1979-07-02 1979-07-02
EP80302190A EP0021847B1 (de) 1979-07-02 1980-06-30 Langwirkende injizierbare Sulfonamid-Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE4166T1 true ATE4166T1 (de) 1983-08-15

Family

ID=21990197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80302190T ATE4166T1 (de) 1979-07-02 1980-06-30 Langwirkende injizierbare sulfonamidzusammensetzungen.

Country Status (10)

Country Link
EP (1) EP0021847B1 (de)
AT (1) ATE4166T1 (de)
DE (1) DE3064250D1 (de)
DK (1) DK283480A (de)
ES (1) ES493006A0 (de)
FI (1) FI72650C (de)
GR (1) GR69205B (de)
IE (1) IE49934B1 (de)
NZ (1) NZ194192A (de)
ZA (1) ZA803937B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
CN102772422B (zh) * 2012-08-22 2014-03-26 郑州福源动物药业有限公司 一种长效复方磺胺二甲嘧啶、巴喹普林注射液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631779A1 (de) * 1976-07-15 1978-01-19 Basf Ag Sulfonamid-trimethoprim-loesungen
IL52533A (en) * 1977-07-15 1980-01-31 Abic Ltd Injectable chloramphenicol composition

Also Published As

Publication number Publication date
FI72650B (fi) 1987-03-31
ES8105146A1 (es) 1981-06-01
FI72650C (fi) 1987-07-10
NZ194192A (en) 1982-11-23
FI802096A (fi) 1981-01-03
ZA803937B (en) 1981-06-24
GR69205B (de) 1982-05-07
DE3064250D1 (en) 1983-08-25
IE801363L (en) 1981-01-02
EP0021847A2 (de) 1981-01-07
IE49934B1 (en) 1986-01-08
EP0021847A3 (en) 1981-08-12
DK283480A (da) 1981-01-03
EP0021847B1 (de) 1983-07-20
ES493006A0 (es) 1981-06-01

Similar Documents

Publication Publication Date Title
SE7906533L (sv) Pyrrolidinderivat
DK0590428T3 (da) Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse
ATE144498T1 (de) Herstellung von substituierten piperidinen
FI881609A0 (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
DE3788585D1 (de) Flüssige Brennstoffzusammensetzungen.
ATE4166T1 (de) Langwirkende injizierbare sulfonamidzusammensetzungen.
BR8203379A (pt) Composicoes herbicidas baseadas em derivados de cloro-aceto-ciclo-alquil-amidas
FI882444A (fi) Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ZA804036B (en) Sulfonamide compositions
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
ATE73812T1 (de) Thionophosphonsaeureester.
ATE61372T1 (de) Thionophosphonsaeureester.
DK143229C (da) Analogifremgangsmaade til fremstilling af (+,-)-cis-alfa-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alfa-phenyl-2-pyridinmethanol eller syreadditionssalte heraf
DK597188D0 (da) 9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxymorphinanderivater
DK144698C (da) 2,4-diamino-6-halogen-5-benzylpyrimidiner til anvendelse som mellemprodukter ved fremstilling af 2,4-diamino-5-benzylpyrimidiner
IT7825587A0 (it) Procedimento per accrescere la stabilita' termica di composizioni polimeriche autoestinguenti.
ES2052810T3 (es) Procedimiento para la obtencion de 4-((met)acrilamidometil)-pirazoles e -isoxazoles asi como su empleo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee